Targanta Therapeutics' Series C Round

Targanta Therapeutics raised a round of funding on January 11, 2002.

Targanta Therapeutics, Inc. (NASDAQ:TARG) is a biotechnology company developing and commercializing antibacterial drugs to treat serious infections in the hospital setting. Targanta's lead drug candid…

Articles about Targanta Therapeutics' Series C Round: